Skip to main content
. 2020 May 30;25(8):e1188–e1194. doi: 10.1634/theoncologist.2020-0161

Figure 3.

Figure 3

CEA response of patients treated with regorafenib and PD‐1 inhibitor. (A): CEA changes in patients with progressive disease. (B): CEA changes in patients with stable disease.

Abbreviations: CEA, carcinoembryonic antigen; PD, progressive disease; SD, stable disease.